<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cancer on Pierre-François Roux</title>
    <link>https://www.pierre-francois-roux.com/tags/cancer/</link>
    <description>Recent content in Cancer on Pierre-François Roux</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <copyright>&amp;copy; 2021 Pierre-François Roux</copyright>
    <lastBuildDate>Fri, 19 Jun 2026 00:00:00 +0000</lastBuildDate>
    
	<atom:link href="https://www.pierre-francois-roux.com/tags/cancer/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>ATAC-seq as an integrative assay for aging and cancer</title>
      <link>https://www.pierre-francois-roux.com/project/atac-seq-as-an-integrative-assay-for-aging-and-cancer/</link>
      <pubDate>Fri, 19 Jun 2026 00:00:00 +0000</pubDate>
      
      <guid>https://www.pierre-francois-roux.com/project/atac-seq-as-an-integrative-assay-for-aging-and-cancer/</guid>
      <description>ATAC-seq is widely used to map chromatin accessibility, but bulk ATAC-seq libraries contain much more information than accessible regulatory elements alone. In recent work, I benchmarked ATAC-seq against matched whole-genome sequencing to evaluate whether a single assay can also recover genetic information relevant to cancer and aging biology.
Using paired datasets from patient-derived melanoma cell lines and TCGA brain tumors, we showed that ATAC-seq can support high-precision small variant detection within accessible regions, robust copy-number profiling, mitochondrial genome characterization and telomere-associated repeat quantification, while preserving its classical epigenomic readouts.</description>
    </item>
    
  </channel>
</rss>